Telmik-Trio 50 Tablet ER

Telmik-Trio 50 Tablet ER belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). Telmik-Trio 50 Tablet ER helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke. High blood pressure is a condition in which the blood exerts increased pressure on the walls of blood vessels. Symptoms include headache, dizziness, nosebleeds, changes in vision, chest pain, weakness, and dyspnea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
 
Telmik-Trio 50 Tablet ER is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol succinate. Cilnidipine acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helping the blood flow smoothly. Telmisartan works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate slows down the rate and makes it easier for the heart to pump blood throughout the body. Together, Telmik-Trio 50 Tablet ER helps treat hypertension.
 
Take Telmik-Trio 50 Tablet ER as prescribed. You are advised to take Telmik-Trio 50 Tablet ER for as long as your doctor has recommended it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, dizziness, weakness, decreased blood pressure, and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Try not to stop taking Telmik-Trio 50 Tablet ER on your own as it may cause a sudden increase in blood pressure. Consult your doctor before taking Telmik-Trio 50 Tablet ER if you are pregnant or breastfeeding. Telmik-Trio 50 Tablet ER is not recommended for children as efficacy and safety have not been established. Telmik-Trio 50 Tablet ER may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects/interactions.

Telmik-Trio 50 Tablet ER is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol succinate. Telmik-Trio 50 Tablet ER is used to treat hypertension. Cilnidipine is a calcium channel blocker that acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helping the blood flow smoothly. Telmisartan is an angiotensin receptor blocker that works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate is a beta-blocker that slows down the rate and makes it easier for the heart to pump blood throughout the body. Together, Telmik-Trio 50 Tablet ER helps treat hypertension. Telmik-Trio 50 Tablet ER helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.

Do not take Telmik-Trio 50 Tablet ER if you are allergic to any of its contents. Inform your doctor before taking Telmik-Trio 50 Tablet ER if you have diabetes, circulation problems, asthma, thyroid disorder, adrenal gland tumour, heart, kidney, or liver problems; if you are on a low-salt diet or if you are taking potassium supplements. Consult your doctor before taking Telmik-Trio 50 Tablet ER if you are pregnant or breastfeeding. Telmik-Trio 50 Tablet ER is not recommended for children as efficacy and safety have not been established. Telmik-Trio 50 Tablet ER may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Rise slowly from lying/sitting position as Telmik-Trio 50 Tablet ER may cause dizziness (orthostatic hypotension).

Regular monitoring of blood pressure levels, kidney function and electrolyte levels while taking Telmik-Trio 50 Tablet ER is advised.